New US patent approval for Episurf Medical
Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “System and method for creating a decision support material indicating damage to an anatomical joint”, is within the area of 3D-based assessment of joint lesions, and complements the company’s previously approved patents within that field. “Our visualisation of joint damage, which includes AI-based 3D-modelling, is unique and we are happy to be able to build a strong patent protection around it”, says Katarina Flodström, COO, Episurf